I. Jarvela et al., The effect of diclofenac on uterine artery blood flow resistance during menstruation in patients with and without a copper intrauterine device, HUM REPR, 13(9), 1998, pp. 2480-2483
The aim was to evaluate the effect of diclofenac on uterine artery blood fl
ow resistance during the first day of menstruation. A total of 28 regularly
menstruating women were examined longitudinally with and without a copper
intrauterine contraceptive device (IUD) by transvaginal colour Doppler ultr
asonography, The uterine artery pulsatility index (PI) was first measured,
after which 50 mg of diclofenac was infused i.v. After 15 min the PI was me
asured again. The patients evaluated their menstrual pain with a scoring sy
stem before and after the diclofenac infusion. The mean PI (SD) during mens
truation was significantly lower with the IUD [2.13 (0.43)] than without [2
.39 (0.62)], P = 0.05. The mean PI in nine patients who experienced advance
d menstrual pain was also lower in the presence of the IUD [2.16 (0.42)] th
an without it [2.83 (0.78); P < 0.05]. Diclofenac was effective in revealin
g menstrual pain both with and without the IUD, and reduced the PI in the a
bsence of an IUD [pre-treatment 2.39 (0.62) versus posttreatment 2.12 (0.45
); P < 0.001], but had no effect when the IUD was present [pre-treatment 2.
13 (0.43) versus post-treatment 2.10 (0.41)]. The results indicate that by
inhibiting prostaglandin synthesis one can reduce the resistance to blood h
ow in the uterine arteries during menstruation. This does not hold true whe
n an IUD is present, however, suggesting that the device might induce the p
roduction of vasoactive agents other than prostaglandins in the surrounding
tissue.